New Technology Gives Surgeons Real-time Microscopic Vision of Brain Tumors
A new laser-based microscopic technology, called a stimulated Raman scattering (SRS) microscope, is now being tested at the University of Michigan Health System, and may help neurosurgeons better see the difference between tumor tissue and normal, healthy brain tissue in real-time. “It allows the surgical decision-making process to become data driven instead of relying on the surgeon’s best guess,” said the neurosurgeon piloting the technology, in collaboration with the pathology department at the University of Michigan Medical School. The team’s research was published in the journal Science Translational Medicine and could be submitted to the FDA for approval within the next two years. The team developing the SRS microscope hopes to create a product about the size of a microwave and one that’s more affordable than the imaging systems currently being used. Researchers believe removing the cost and space-capacity barriers will make this technology appealing to many surgeons. “This technology has the potential to resolve a long-standing issue in cancer surgery, which is the need for faster and more effective methods to assess whether a tumor has been fully removed,” said the director of the Division of Applied Science & Technology at the National Institutes of Health. To read more about this technology, click here.
NeuroSafe 2019 Symposium
Aug. 8-9, 2019; Minneapolis
SNSA Congress 2019
Aug. 8-11, 2019; Cape Town, South Africa
2019 Managing Coding and Reimbursement Challenges
Aug. 22-24, 2019; Rosemont, Ill.
2019 From Cranial to Spine: An Overview of Neurosurgical Topics for the Advanced Practice Provider
Aug. 28-31, 2019; Orlando, Fla.
Sept. 8-11, 2019; Leuven, Belgium